Pressure BioSciences, Inc. (PBIO)
-OTC Markets 0.38 0.00(0.00%) May 17, 3:59PM EDT
| Prev Close: | 0.38 |
|---|
| Open: | 0.36 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 5.00 |
|---|
| Beta: | 0.55 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.36 - 0.38 |
|---|
| 52wk Range: | 0.15 - 0.63 |
|---|
| Volume: | 18,150 |
|---|
| Avg Vol (3m): | 35,456 |
|---|
| Market Cap: | 4.44M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.58 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Breakthrough Method for Lipid Analysis in Fecal Material Developed; New Understanding of Diseases/Disorders Related to Gut Function PossiblePR Newswire(Thu, May 16)
- PRESSURE BIOSCIENCES INC Files SEC form 10-K, Annual ReportEDGAR Online(Mon, May 13)
- First Quarter 10Q for Pressure BioSciences Inc.WILink(Wed, Apr 24)
- Galena Pharma: High Hopes For The Sharesat Seeking Alpha(Mon, Apr 8)
- Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences' Patented Pressure Cycling Technology (PCT)PR Newswire(Thu, Apr 4)
- New Applications of Pressure BioSciences' PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein ResearchPR Newswire(Tue, Mar 19)
- Pressure BioSciences, Inc. to Present at the SeeThruEquity Spring Investor Microcap ForumPR Newswire(Mon, Mar 11)
- Pressure BioSciences (PBIO), High Growth Expected for 2013 and BeyondZacks(Tue, Mar 5)
- PRESSURE BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of EquityEDGAR Online(Wed, Feb 13)
- Dr. Mickey Urdea Joins Pressure BioSciences' Board of DirectorsPR Newswire(Tue, Feb 12)
- PRESSURE BIOSCIENCES INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Unregistered Sale of EquitEDGAR Online(Fri, Jan 4)
- Thermo Fisher Maintained at NeutralZacks(Fri, Jan 4)
- PRESSURE BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of InEDGAR Online(Thu, Jan 3)
- PRESSURE BIOSCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Mon, Dec 17)
- PRESSURE BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhiEDGAR Online(Tue, Dec 11)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 3.27 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-11)
: | N/A |
|---|
| Quarterly EPS Est
(Sep-11)
: | N/A |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Pressure BioSciences, Inc., a life sciences company, engages in the development and commercialization of pressure cycling technology (PCT) in the United States.
View More 
0.80%